NCATS Advisory Council Roster
| Chairperson Christopher P. Austin, M.D. Director National Center for Advancing Translational Sciences National Institutes of Health Bethesda, Md. | Executive Secretary Danilo A. Tagle, M.S., Ph.D. Acting Director Office of Grants Management and Scientific Review National Center for Advancing Translational Sciences National Institutes of Health Bethesda, Md. |
Council Members*
(Terms end 9/30 of designated year.)
| Margaret A. Anderson, M.A. (2014) Executive Director FasterCures Center for Accelerating Medical Solutions Washington, D.C. R. Alta Charo, J.D. (2016) Warren P. Knowles Professor of Law & Bioethics University of Wisconsin Law School and School of Medicine & Public Health Madison, Wis. Jorge L. Contreras, J.D. (2014) Associate Professor Washington College of Law American University Washington, D.C. Pamela B. Davis, M.D., Ph.D. (2015) Dean and Vice President for Medical Affairs Office of the Dean Case Western Reserve University Cleveland, Ohio Louis J. DeGennaro, Ph.D. (2014) Chief Mission Officer Leukemia & Lymphoma Society White Plains, N.Y. Mary L. Disis, M.D. (2015) Professor, Department of Medicine Division of Oncology University of Washington School of Medicine Seattle, Wash. Frank L. Douglas, Ph.D., M.D. (2016) President and CEO Austen BioInnovation Institute in Akron Akron, Ohio Geoffrey S. Ginsburg, M.D., Ph.D. (2016) Director of Genomic Medicine Institute for Genome Sciences and Policy Executive Director, Center for Personalized Medicine Duke University Health System Professor of Medicine and Pathology Duke University School of Medicine Durham, N.C. | Eric D. Kodish, M.D. (2014) F.J. O'Neill Professor and Chairman Department of Bioethics Cleveland Clinic Foundation Cleveland, Ohio Freda C. Lewis-Hall, M.D. (2015) Chief Medical Officer Pfizer New York, N.Y. Bernard H. Munos, M.B.A. (2016) Founder InnoThink Center for Research in Biomedical Innovation Indianapolis, Ind. Franklyn G. Prendergast, M.D., Ph.D. (2014) Professor of Pharmacology and of Molecular Pharmacology and Experimental Therapeutics Mayo Medical School Rochester, Minn. Todd B. Sherer, Ph.D. (2015) CEO Michael J. Fox Foundation for Parkinson's Research New York, N.Y. Scott J. Weir, Pharm.D., Ph.D. (2016) Director Institute for Advancing Medical Innovation University of Kansas Cancer Center Kansas City, Kan. Paul G. Yock, M.D. (2014) Martha Meier Weiland Professor Departments of Bioengineering and Medicine, Program in Biodesign Stanford University Stanford, Calif. |
Representative Members
| Ankit A. Mahadevia, M.D., M.B.A. (2016) Principal Atlas Venture Cambridge, Mass. | Robert I. Tepper, M.D. (2016) Partner Third Rock Ventures, LLC Boston, Mass. |
Ex Officio Members
| Office of the Secretary, DHHS Kathleen Sebelius Secretary Department of Health and Human Services Washington, D.C. | National Institutes of Health Francis S. Collins, M.D., Ph.D. Director Bethesda, Md. |
Members of the NCATS Advisory Council also serve on the Cures Acceleration Network Review Board.
*One vacancy due to a deferral.
Social Media Links